SkyCell

PharmaLifeScience News

...

Roche builds in obesity with $5.3bn Zealand licensing deal

Roche has parted with $1.4 billion upfront to secure rights to an obesity candidate developed by Zealand Pharma, taking its tally of weight-loss candidates in clinical development to five.

READ MORE
...

The looming antibiotic emergency and why the time for global action is now
The fight against antimicrobial resistance is reaching a critical moment: drug-resistant infections are outpacing our ability to treat them
READ MORE
...

Manchester looks to build on life sciences cluster effect
The city’s ecosystem of universities, commerce and research is attracting investors and start-ups
READ MORE

Canada and Alberta governments to invest in Entos R&D facility

Trump accuses Ireland of stealing US pharmaceutical industry in meeting with Taoiseach

WuXi XDC and AbTis collaborate on antibody-drug conjugates

Guardpack secures funding for moves into medical device production

MSD bolsters US manufacturing capacity with $1b investment

Douglas Kelly, deputy science director at FDA’s device center, leaves agency

ElevateBio taps Amazon’s genAI tools to design CRISPR therapeutics

Vanderbilt researchers aim to use AI to develop antibody therapies for any target

MSD opens $1bn plant for HPV vaccine in the US

Healthcare tackles AI oversight with no aid from Trump administration

$30 Million Grant Supports AI-Powered Antibody Therapy Development

Scientific 'superintelligence' firm Lila launches with $200m

Beam launches $500m financing on base-editing trial data

IgE antibodies show promise in targeting HER2 cancers resistant to other therapies

Research Ireland awards scientist €3.5m to advance biotherapeutics

Boule Diagnostics closes BM950 project and announces new portfolio strategy

Machine learning models fall short in predicting in-hospital mortality

Artificial intelligence is making clinical supply chains more efficient and more sustainable: here’s how

Galway’s SymPhysis aims for a US launch by next year

Scientists Develop Off-the-Shelf Vascular Grafts Using Stem Cells

Flagship startup raises $200M in pursuit of ‘scientific superintelligence’
Ellab